This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 Mar;3(3):181-2.

doi: 10.1093/oxfordjournals.annonc.a058144.

Anthracyclines active via the oral route: luxury or necessity?

M J Piccart, D de Valeriola, E Tomiak

PMID: 1534020
DOI: 10.1093/oxfordjournals.annonc.a058144

Free article

Editorial

Anthracyclines active via the oral route: luxury or necessity?

M J Piccart et al. Ann Oncol. 1992 Mar.

Free article

. 1992 Mar;3(3):181-2.

doi: 10.1093/oxfordjournals.annonc.a058144.

Authors

M J Piccart, D de Valeriola, E Tomiak

PMID: 1534020
DOI: 10.1093/oxfordjournals.annonc.a058144

No abstract available

PubMed Disclaimer

Comment on

Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
Stewart DJ, Eisenhauer EA, Skillings J, Pritchard KI, Buckman R, VAndenberg T, Verma S, Aitken S, Norris B. Stewart DJ, et al. Ann Oncol. 1992 Mar;3(3):201-4. doi: 10.1093/oxfordjournals.annonc.a058152. Ann Oncol. 1992. PMID: 1534021 Clinical Trial.

Similar articles

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Sessa C, Kaye SB, Renard J, ten Bokkel Huinink W, Cavalli F. Sessa C, et al. Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9. Eur J Cancer Clin Oncol. 1989. PMID: 2523809 No abstract available.
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Brown TD, Goodman PJ, Fleming TR, Baker LH, Macdonald JS. Brown TD, et al. Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550. Invest New Drugs. 1991. PMID: 1827433 Clinical Trial. No abstract available.
Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.
Conley BA, Egorin MJ, Sinibaldi V, Van Echo DA. Conley BA, et al. Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592. Invest New Drugs. 1990. PMID: 2150671 Clinical Trial. No abstract available.
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
Wadler S, Fuks JZ, Wiernik PH. Wadler S, et al. J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW, Raymond V. Young CW, et al. Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.

See all similar articles

Cited by

Potential role of oral anthracyclines in older patients with cancer.
Lasota WS, de Valeriola DL, Piccart MJ. Lasota WS, et al. Drugs Aging. 1994 May;4(5):392-402. doi: 10.2165/00002512-199404050-00004. Drugs Aging. 1994. PMID: 8043941 Review.
Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.
Whittington R, Goa KL. Whittington R, et al. Pharmacoeconomics. 1993 Oct;4(4):287-307. doi: 10.2165/00019053-199304040-00007. Pharmacoeconomics. 1993. PMID: 10146918 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science